Jay R. Venkatesan

President & Chief Executive Officer at Angion Biomedica Corp.

Jay R. Venkatesan

Jay R. Venkatesan

President & Chief Executive Officer at Angion Biomedica Corp.

Overview
Career Highlights

Varro Technologies, Inc.
Alpine Immune Sciences, Inc.
Nivalis Therapeutics, Inc.

RelSci Relationships

470

Number of Boards

14

Birthday

1972

Age

47

Relationships
RelSci Relationships are individuals Jay R. Venkatesan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Exicure Operating Co.

Relationship likelihood: Strong

Chief Executive Officer at Exicure Operating Co.

Relationship likelihood: Strong

Executive Chairman & Chief Executive Officer at Alpine Immune Sciences, Inc.

Relationship likelihood: Strong

Strategic Advisor at The Column Group LLC

Relationship likelihood: Strong

Co-Founder at Quanterix Corp.

Relationship likelihood: Strong

Executive Chairman & Chief Scientific Officer at Angion Biomedica Corp.

Relationship likelihood: Strong

President & Chief Executive Officer at eGenesis, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer at Array BioPharma Inc.

Relationship likelihood: Strong

Managing General Partner at Frazier Management LLC

Relationship likelihood: Strong

Co-Founder, Director at Cleave Biosciences, Inc.

Relationship likelihood: Strong

Paths to Jay R. Venkatesan
Potential Connections via
Relationship Science
You
Jay R. Venkatesan
President & Chief Executive Officer at Angion Biomedica Corp.
Career History
Professional
Prior

Patricof & Co. Ventures, Inc. is a leading international private equity investment firm.

Consultant
1993 - 1995

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

President & Treasurer
2000 - Current

Varro Technologies, Inc. develops distributed knowledge management applications for the life science industry. It offers a patent-pending technology solution for accessing, managing, and sharing the genetic information. The company was founded by Jay Venkatesan, David Sullivan Shin, Wesley Chan, and Chester M Hedgepeth III on December 22, 2000 and is headquartered in Philadelphia, PA.

Boards & Committees
Member, Board of Directors
2017 - Current
Member, Board of Directors
2014 - Current
Member, Board of Directors
2014 - Current
Political Donations
$2,500
2011
Transactions
Details Hidden

Angion Biomedica Corp. raised money in a private placement transaction

Details Hidden

Angion Biomedica Corp. raised money in a private placement transaction

Details Hidden

Cascadian Therapeutics, Inc. raised money in a private placement transaction

Investments
Details Hidden

Varro Technologies, Inc. develops distributed knowledge management applications for the life science industry. It offers a patent-pending technology solution for accessing, managing, and sharing the genetic information. The company was founded by Jay Venkatesan, David Sullivan Shin, Wesley Chan, and Chester M Hedgepeth III on December 22, 2000 and is headquartered in Philadelphia, PA.

Details Hidden

Tangerine Technologies, Inc. provides software development and business process outsourcing solutions. The company was founded by Jay Venkatesan and Todd Riley Johnson in 2003 and is headquartered in Santa Clara, CA.

Public Holdings
Restricted data only for RelSci Professional users.
Events
Speaker
2012 University of Virginia Investing Conference

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jay R. Venkatesan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jay R. Venkatesan's profile does not indicate a business or promotional relationship of any kind between RelSci and Jay R. Venkatesan.